IVZ
49
-3
UHS
54
-4
SWK
56
-6
AVY
53
2
CNP
50
-2
VNO
60
8
KHC
17
4
COF
63
-4
HSY
43
3
ADI
45
-5
JCI
61
-2
STI
31
19
HCP
70
-4
EXPE
96
-3
SLG
62
-4
EW
32
3
MMM
42
5
ZTS
49
2
LEN
52
2
DG
12
2
IVZ
49
-3
UHS
54
-4
SWK
56
-6
AVY
53
2
CNP
50
-2
VNO
60
8
KHC
17
4
COF
63
-4
HSY
43
3
ADI
45
-5
JCI
61
-2
STI
31
19
HCP
70
-4
EXPE
96
-3
SLG
62
-4
EW
32
3
MMM
42
5
ZTS
49
2
LEN
52
2
DG
12
2
Financhill
Back

Heron Therapeutics Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
14

HRTX
Heron Therapeutics

Last Price:
1.25
Seasonality Move:
14.98%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Heron Therapeutics Price Quote

$1.25
+0.04 (+3.31%)
(Updated: November 14, 2024 at 5:15 PM ET)

Heron Therapeutics Key Stats

Sell
14
Heron Therapeutics (HRTX) is a Sell
Day range:
$1.18 - $1.36
52-week range:
$0.53 - $3.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.41
P/B ratio:
0%
Volume:
2.8M
Avg. volume:
1.7M
1-year change:
121.69%
Market cap:
$194.1M
Revenue:
$127M
EPS:
$-0.3

How Much Does Heron Therapeutics Make?

Is Heron Therapeutics Growing As A Company?

  • What Is Heron Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.13%
  • What Is Heron Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Heron Therapeutics Stock Price Performance

What Is Heron Therapeutics 52-Week High & Low?

Heron Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Heron Therapeutics?

  • How Much Debt Does Heron Therapeutics Have?
    Total long term debt quarterly is $174.2M
  • How Much Cash Does Heron Therapeutics Have?
    Cash and short term investments quarterly total is $67.3M
  • What Is Heron Therapeutics’s Book Value Per Share?
    Book value per share is -0.25

Is Heron Therapeutics Cash Flow Positive?

  • What Is HRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$20.8M
  • What Is Heron Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.5M
  • What Is Heron Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$28.7M

Heron Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    HRTX return on invested capital is -35.81%
  • What Is Heron Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -22.1%
  • What Is HRTX Return On Equity?
    ROE is a measure of profitability and is 0%

Heron Therapeutics Earnings Date & Stock Price

Heron Therapeutics Competitors

  • Who Are Heron Therapeutics's Competitors?
    Below is a list of companies who compete with Heron Therapeutics or are related in some way:
    • Journey Medical Corp (DERM)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Heron Therapeutics Dividend Yield

Heron Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.29%
Revenue: 13.42% -11.16%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 478.51%

Major Shareholders

  • How many HRTX shares are owned by institutional investors?
    156M HRTX shares are owned by institutional investors
  • How many HRTX shares are owned by insiders?
    2.7M HRTX shares are owned by insiders